NEBBIOSO, Angela
 Distribuzione geografica
Continente #
EU - Europa 5.915
NA - Nord America 3.664
AS - Asia 3.412
SA - Sud America 682
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 13.733
Nazione #
US - Stati Uniti d'America 3.607
RU - Federazione Russa 2.415
SG - Singapore 1.185
IE - Irlanda 1.053
IT - Italia 820
CN - Cina 773
HK - Hong Kong 646
BR - Brasile 588
UA - Ucraina 394
GB - Regno Unito 372
DE - Germania 322
KR - Corea 221
VN - Vietnam 208
FI - Finlandia 121
SE - Svezia 113
IN - India 103
GR - Grecia 84
TR - Turchia 79
FR - Francia 62
JP - Giappone 49
AR - Argentina 44
NL - Olanda 29
PK - Pakistan 29
MX - Messico 28
BE - Belgio 23
CA - Canada 22
ID - Indonesia 20
IQ - Iraq 20
ZA - Sudafrica 18
AT - Austria 17
BD - Bangladesh 16
EC - Ecuador 14
PL - Polonia 13
UZ - Uzbekistan 13
HU - Ungheria 11
ES - Italia 10
MA - Marocco 9
CO - Colombia 8
CL - Cile 7
VE - Venezuela 7
BG - Bulgaria 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
ET - Etiopia 5
EU - Europa 5
LT - Lituania 5
NO - Norvegia 5
RO - Romania 5
SA - Arabia Saudita 5
SI - Slovenia 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
EG - Egitto 4
KZ - Kazakistan 4
LV - Lettonia 4
NP - Nepal 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BO - Bolivia 3
DZ - Algeria 3
IL - Israele 3
IR - Iran 3
OM - Oman 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
AU - Australia 2
BW - Botswana 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CD - Congo 1
CH - Svizzera 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.733
Città #
Dublin 1.053
Moscow 777
Hong Kong 642
Santa Clara 606
Jacksonville 604
Singapore 542
Chandler 499
Seoul 211
Caserta 172
Beijing 157
Princeton 132
Medford 116
Hefei 113
Ann Arbor 99
Ashburn 98
Naples 92
Boardman 91
Roxbury 85
Bengaluru 64
Wilmington 64
Munich 63
Bremen 62
São Paulo 61
Ho Chi Minh City 59
The Dalles 58
New York 52
San Mateo 52
Napoli 42
Hanoi 41
Dallas 38
Woodbridge 34
Cambridge 33
Rio de Janeiro 31
Dong Ket 30
Aversa 28
Des Moines 28
Los Angeles 27
Rome 27
Nuremberg 26
Milan 24
Brussels 23
Nanjing 23
Mountain View 21
Jinan 17
Norwalk 17
Düsseldorf 16
Redwood City 16
Tianjin 14
Turku 14
Boston 13
Guangzhou 13
Salvador 13
Amsterdam 11
Brooklyn 11
Ercolano 11
Ferrara 11
Lappeenranta 11
Tashkent 11
Vienna 11
Belo Horizonte 10
Biên Hòa 10
Buenos Aires 10
Changsha 10
Hangzhou 10
Helsinki 10
Houston 10
London 10
Nanchang 10
Warsaw 10
Auburn Hills 9
St Petersburg 9
Brasília 8
Frankfurt am Main 8
Istanbul 8
Johannesburg 8
Pomigliano d'Arco 8
Porto Alegre 8
Viterbo 8
Cicciano 7
Falls Church 7
Florence 7
Fortaleza 7
Ioannina 7
Jakarta 7
Ribeirão Preto 7
Shenyang 7
Venice 7
Campinas 6
Council Bluffs 6
Da Nang 6
Elora 6
Hortolândia 6
Lisbon 6
Mexico City 6
Quito 6
Recife 6
Seattle 6
Shanghai 6
Thái Nguyên 6
Bacoli 5
Totale 7.624
Nome #
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 158
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondria! Function and Exhibit Inhibition of Proliferation in Cancer Cells 152
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin 151
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 149
Molecular Profiling of Human Primary Chondrosarcoma-Derived Spheres Reveals Specific and Target Genes Involved in Multidrug Resistance and Metastasis 141
1,3,4-oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. 138
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities 134
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 127
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 125
ATTIVITÀ ANTI-PROLIFERATIVA E DIFFERENZIANTE INDOTTA DAL FRUTTO DI PSIDIUM GUAJAVA IN CELLULE LEUCEMICHE UMANE 125
The clinical value of HDAC2 and the p53-dependent signalling pathway in colorectal cancer 124
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 124
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 121
Forskolin potentiates the effects of GSKJ4 in human acute myeloid leukemia cells through Protein Kinase A pathway 119
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 119
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells 118
APOPTOSI INDOTTA DALL' ESTRATTO TOTALE ACETONICO DEL FRUTTO DI FEIJOA SELLOWIANA (BERG) IN CELLULE LEUCEMICHE UMANE 118
BARD1 is a target of miR-19a and miR-19b: a new selective epigenetic therapy for acute myeloid lekaemias? 117
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 116
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. 116
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 116
Characterization of Histone Acetyltransferase-1 in cancer cells 116
Combined HAT/EZH2 modulation leads to cancer-selective cell death 114
Comparative phytochemical characterization, genetic profile, and antiproliferative activity of polyphenol-rich extracts from pigmented tubers of different solanum tuberosum varieties 113
Natural compounds in epigenetics: A current view. 111
The Role of Ozone Carried by Liposomes in the Therapy of Infectious and Skin-Regenerating Ocular Surface 111
ATTIVITA’ ANTITUMORALE DEL FLAVONE NATURALE PURIFICATO DA FEIJOA SELLOWIANA IN CELLULE DI LEUCEMIA MIELOIDE ACUTA 108
The m6A-independent role of epitranscriptomic factors in cancer 106
Bispyridinium Dienes, Histone Deacetylase Inhibitors With Selective Activities 105
Cancer epigenetics: Moving forward 105
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer 105
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. 104
Cardioprotective effect of a moderate and prolonged exercise training involves sirtuin pathway. 104
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 102
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity 102
ATTIVATORI DI SIRTUINE E LORO USI 102
Le basi cellulari e molecolari delle malattie per le lauree triennali e magistrali 101
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 100
"Stockpile" of Slight Transcriptomic Changes Determines the Indirect Genotoxicity of Low-Dose BPA in Thyroid Cells 100
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 100
Developing novel non-hydroxamate histone deacetylase inhibitors: The chelidamic warhead 99
Identification of NuRSERY, a New Functional HDAC Complex Composed by HDAC5, GATA1, EKLF and pERK Present in Human Erythroid Cells. 98
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes 98
Acute myeloid leukemia: Therapeutic impact of epigenetic drugs 98
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia 98
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition 98
3-Chloro-N '-(2-hydroxybenzylidene)benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy 96
PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia 95
AZIONE "TUMORE-SELETTIVA" DEGLI INIBITORI DELLE ISTONE DEACETILASI IN LEUCEMIE MIELOIDI ACUTE 95
Designing Novel Dual Transglutaminase 2 / Histone Deacetylase Inhibitors Effective in Halting Neuronal Death 95
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line 95
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells 94
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells 94
RIPK1-targeting in cancer: modulation of programmed cell death process for cancer treatment 94
Identification of two New Synthetic Histone Deacetylase Inhibitors that Modulate Globin Gene Expression in Erythroid Cells from Normal Donors and Thalassemic Patients 93
Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors 93
Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors 93
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 92
Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors 92
Identification and characterization of PKF118-310 as a KDM4A inhibitor 92
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 92
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 91
TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule 91
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues 91
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity 91
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease 91
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 90
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b. 89
Forskolin sensitizes human acute myeloid leukemia cells to H3K27me2/3 demethylases GSKJ4 inhibitor via Protein Kinase A 89
Cytotoxic Potential of the Marine Diatom Thalassiosira rotula: Insights into Bioactivity of 24-Methylene Cholesterol 88
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer 87
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring. 86
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 86
Targeting ROS production through inhibition of NADPH oxidases 85
Class II (IIa)-Selective Histone Deacetylase Inhibitors: Synthesis and Biological Evaluation of Novel (Aryloxopropenyl)pyrrolyl Hydroxyamides 85
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability 85
Pyrrole-Based Hydroxamates and 2-Aminoanilides: Histone Deacetylase Inhibition and Cellular Activities 84
FEIJOA SELLOWIANA DERIVED NATURAL FLAVONE EXERTS ANTI-CANCER ACTION DISPLAYING HDAC INHIBITORY ACTIVITIES 84
Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases 83
Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells. 83
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation 83
L’ AZIONE TUMORE-SELETTIVA DEGLI INIBITORI DELLE ISTONE-DEACETILASI COINVOLGE L’INDUZIONE DI TRAIL IN CELLULE DI LEUCEMIA MIELOIDE ACUTA 82
N{varepsilon}-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart 82
SIRT1 Activation by Natural Phytochemicals: An Overview 82
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect 81
Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome 81
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer 81
Gene transactivation and transrepression in myc-driven cancers 81
Growth factor-antagonized rexinoid apoptosis involves permissive PPARgamma/RXR heterodimers to activate the intrinsic death pathway by NO 80
Small-Molecule Inhibitors of Histone Acetyltransferase Activity: Identification and Biological Properties 80
Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studies. 80
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukemia cells 78
KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches 78
EPIGENETIC MODULATION OF LAT1 EXPRESSION TO ENHANCE OSTEOSARCOMA SENSITIVITY TO BORON NEUTRON CAPTURE THERAPY (BNCT) 77
epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors 77
Trifolium Repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway 77
Nonlinear protein – nucleic acid crosslinking induced by femtosecond UV laser pulses in living cells 76
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia 76
The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer 76
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 76
Totale 9.954
Categoria #
all - tutte 54.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021613 0 0 0 0 0 8 170 102 45 120 111 57
2021/2022849 60 12 15 38 279 13 16 24 38 39 59 256
2022/20232.004 161 57 52 159 204 155 1 92 993 14 50 66
2023/2024772 77 26 37 60 240 76 23 25 4 10 69 125
2024/20252.579 32 25 90 78 407 356 454 234 238 282 203 180
2025/20265.082 470 531 497 632 856 2.096 0 0 0 0 0 0
Totale 14.053